Trexquant Investment LP Harrow Health, Inc. Transaction History

Trexquant Investment LP

$8.35 Billion
Q2 2025

A detailed history of Trexquant Investment LP transactions in Harrow Health, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 17,966 shares of HROW stock, worth $745,589. This represents 0.01% of its overall portfolio holdings.

Number of Shares

17,966

Previous 9,647 86.23%

Holding current value

$745,589

Previous $256,000 114.06%

% of portfolio

0.01%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$22.2 - $31.61 $184,681 - $262,963	8,319 Added 86.23%	17,966 $548,000
Q1 2025 May 14, 2025	SELL	$22.22 - $36.67 $1.89 Million - $3.11 Million	-84,853 Reduced 89.79%	9,647 $256,000
Q4 2024 Feb 12, 2025	BUY	$33.39 - $57.5 $2.99 Million - $5.15 Million	89,544 Added 1806.78%	94,500 $3.17 Million
Q3 2024 Nov 12, 2024	SELL	$20.85 - $46.47 $162,671 - $362,558	-7,802 Reduced 61.15%	4,956 $222,000
Q2 2024 Aug 13, 2024	BUY	$10.0 - $21.64 $127,580 - $276,083	12,758 New	12,758 $266,000
Q3 2023 Nov 13, 2023	BUY	$14.03 - $22.08 $617,123 - $971,210	43,986 New	43,986 $632,000
Q4 2022 Feb 13, 2023	SELL	$10.28 - $14.78 $246,236 - $354,025	-23,953 Reduced 40.6%	35,039 $517,000
Q3 2022 Nov 14, 2022	BUY	$6.57 - $24.88 $194,859 - $737,915	29,659 Added 101.11%	58,992 $712,000
Q2 2022 Aug 11, 2022	BUY	$5.75 - $7.74 $93,799 - $126,262	16,313 Added 125.29%	29,333 $214,000
Q1 2022 May 13, 2022	BUY	$6.77 - $8.66 $12,104 - $15,484	1,788 Added 15.92%	13,020 $89,000
Q4 2021 Feb 14, 2022	BUY	$8.5 - $12.0 $95,472 - $134,784	11,232 New	11,232 $97,000
Q2 2021 Aug 12, 2021	SELL	$6.68 - $11.07 $163,960 - $271,713	-24,545 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$6.26 - $11.03 $73,648 - $129,767	-11,765 Reduced 32.4%	24,545 $166,000
Q4 2020 Feb 11, 2021	BUY	$4.76 - $6.93 $95,038 - $138,364	19,966 Added 122.16%	36,310 $249,000
Q3 2020 Nov 06, 2020	BUY	$4.71 - $7.36 $76,980 - $120,291	16,344 New	16,344 $91,000
Q2 2019 Aug 09, 2019	SELL	$4.2 - $8.7 $64,814 - $134,258	-15,432 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$4.75 - $7.1 $73,302 - $109,567	15,432 New	15,432 $77,000

Others Institutions Holding HROW

# of Institutions

183

Shares Held

21.6M

Call Options Held

390K

Put Options Held

413K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $1.12B
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Harrow Health, Inc. Transaction History